- Report
- August 2026
- 120 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- August 2026
- 111 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- August 2026
- 130 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- July 2026
- 180 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- January 2026
- 280 Pages
Global
From €2657EUR$3,000USD£2,276GBP
- Report
- November 2025
- 200 Pages
Global
From €7040EUR$7,950USD£6,032GBP
- Report
- November 2025
- 200 Pages
Global
From €7040EUR$7,950USD£6,032GBP
- Report
- January 2026
- 550 Pages
Global
From €4428EUR$5,000USD£3,794GBP
- Report
- July 2026
- 124 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- July 2026
- 115 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- July 2026
- 120 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- July 2026
- 110 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- July 2026
- 114 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- July 2026
- 110 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- June 2026
- 115 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- June 2026
- 180 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- May 2026
- 180 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- May 2026
- 140 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- April 2026
- 104 Pages
Global
From €4206EUR$4,750USD£3,604GBP
- Report
- May 2026
- 350 Pages
Global
From €4383EUR$4,949USD£3,755GBP

Gene Editing is a technology used in genomics to modify the genetic material of living organisms. It is used to make changes to the DNA sequence of a gene, such as deleting, inserting, or replacing a gene. This technology has been used to create genetically modified organisms, which have been used in research and medical applications. It has also been used to create gene therapies, which are treatments that use gene editing to modify a patient's genetic material to treat a disease.
Gene Editing is a rapidly growing market, with many companies developing new technologies and applications. Companies such as Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Sangamo Therapeutics are leading the way in developing gene editing technologies and treatments. Other companies such as Cellectis, Caribou Biosciences, and Twist Bioscience are also developing gene editing technologies and products. Show Less Read more